Home / Products / Cancer (Tumor) Cell Lines / KYSE-450
KYSE-450
Datasheet Protocol

KYSE-450

Cat. No. ARC0424
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Esophagus

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

KYSE-450 is a cancer cell line of esophagus squamous cell carcinoma, isolated from in situ; esophagus.
 
Synonym: KYSE 450; KYSE450

Recommended Products

FZD2 Knockout NCI-H1975 Polyclonal Cells FZD2 Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG16448 APRT Knockout A549 Polyclonal Cells APRT Knockout A549 Polyclonal Cells Cat. No. ARG19918 ATF3 Knockout Hela Polyclonal Cells ATF3 Knockout Hela Polyclonal Cells Cat. No. ARG37233 DPH5 Knockout jurkat Polyclonal Cells DPH5 Knockout jurkat Polyclonal Cells Cat. No. ARG39654 ARL14EP Knockout AGS Polyclonal Cells ARL14EP Knockout AGS Polyclonal Cells Cat. No. ARG26646 NELFE Knockout Hela Polyclonal Cells NELFE Knockout Hela Polyclonal Cells Cat. No. ARG7533
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Esophagus
Disease:
Squamous cell carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
59 years
Sex of Donor:
Male
Derived From Site:
In situ; Esophagus
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

GMDS Knockout A2780 Polyclonal Cells

GMDS Knockout A2780 Polyclonal Cells

Cat. No. ARG19082
 MYO6 Knockout NCI-H1975 Polyclonal Cells

MYO6 Knockout NCI-H1975 Polyclonal Cells

Cat. No. ARG16388
 FTH1 Knockout CAL27 Polyclonal Cells

FTH1 Knockout CAL27 Polyclonal Cells

Cat. No. ARG11518
 PDK2 Knockout THP-1 Polyclonal Cells

PDK2 Knockout THP-1 Polyclonal Cells

Cat. No. ARG7423
 IL31 Knockout HAP1 Polyclonal Cells

IL31 Knockout HAP1 Polyclonal Cells

Cat. No. ARG22788
 NTN1 Knockout KYSE30 Polyclonal Cells

NTN1 Knockout KYSE30 Polyclonal Cells

Cat. No. ARG9741